| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.5 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |